Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

VRML $1.39 0.0800 +6.11%
KERX $5.44 0.1800 +3.42%
MDVN $57.80 1.6300 +2.90%
NLNK $16.21 0.3300 +2.08%
MNTA $9.51 0.1900 +2.04%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

IMGN $6.85 -1.6000 -18.93%
ARGS $6.24 -0.8500 -11.99%
GILD $88.21 -8.7900 -9.06%
OMED $12.40 -1.1700 -8.62%
AGEN $3.52 -0.3200 -8.33%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

Leica Biosystems and Merrimack Pharmaceuticals to Collaborate on Development of a Heregulin Companion Diagnostic for Seribantumab

(Yahoo! Finance) Apr 15, 2016 - Leica Biosystems and Merrimack Pharmaceuticals today announced a strategic partnership to develop companion diagnostic assays to aid in identification of patients who might best respond to current and future oncology therapies developed by Merrimack.
read article 



EU Extends Safety Review Of Chronic Hep C Treatments

(Reuters) Apr 15, 2016 - The European health regulator said it extended a safety review of chronic hepatitis C treatments after new data showed patients taking the drugs were at risk of their liver cancer returning.
read article 



CMS Hosting April 26 Virtual Office Hour on PQRS Reporting Measures

(ACCC) Apr 14, 2016 - The Centers for Medicare & Medicaid Services (CMS) will host the second session of a three-part Virtual Office Hours series regarding 2016 Physician Quality Reporting System (PQRS) quality measures.
read article 



An Update on the Oncology Medical Home Model at the COA Conference

(AJMC) Apr 14, 2016 - Representatives from 3 clinics that successfully participated in the Commission on Cancer accreditation process for the Oncology Medical Home model participated in a panel discussion on the first day of The Community Oncology Conference: Innovation in Cancer Care.
read article 



Aligning Reimbursement With Quality: Are We There Yet?

(AJMC) Apr 14, 2016 - On the first day of The Community Oncology Conference: Innovation in Cancer Care, held in Orlando, Florida, April 13-15, 2016, oncologists discussed how their practices are coping with the transition toward quality- and value-based reimbursement.
read article 



Combination Therapy May Offer Better Outcomes for Patients with Retinoblastoma

(CHLA) Apr 14, 2016 - Use of chemotherapy with a survivin inhibitor improves treatment responses in retinoblastoma cells and ocular tumor models.
read press release 



No Survival Advantage in Pancreatic Ca With Metformin

(MedPage Today/The Gupta Guide) Apr 14, 2016 - The use of metformin in pancreatic ductal adenocarcinoma (PDAC) does not appear to confer a survival advantage, results from a retrospective analysis of a large cohort showed.
read article (free registration required) 



Small GISTs More Deadly Than Previously Thought

(Medscape Medical News ) Apr 14, 2016 - Small gastrointestinal stromal tumors (GISTs) measuring less than 2 cm, although rare, might be more aggressive than previously thought, according to a study published online March 29 in the Journal of Gastrointestinal Surgery.
read article (free registration required) 



Gene-editing Tool Can Improve Efficacy of Adoptive T-cell Immunotherapy

(AACR) Apr 15, 2016 - The gene-editing tool TALEN can be used to inactivate PD-1-mediated immunosuppression and enhance the efficacy of a type of immunotherapy called adoptive T-cell transfer against solid tumors, according to a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.
read press release 



ARIAD Presents Updated Phase 1/2 Clinical Data on Brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer

(Morningstar) Apr 15, 2016 - ARIAD Pharmaceuticals, Inc. today announced updated clinical data on its investigational tyrosine kinase inhibitor, brigatinib, in patients with advanced malignancies, including anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC), from an ongoing Phase 1/2 trial.
read article 



ELCC 2016 News: Possibility of Overtreatment Linked to Clinically-Diagnosed Early-Stage Lung Cancer

(ESMO) Apr 14, 2016 - Obtaining pathologic diagnosis for patients with early stage lung cancer is often difficult due to medical comorbidities, tumour location, or patient preference.
read article 



ELCC 2016 News: Elderly Patients with Malignant Pleural Mesothelioma Should Not Be Excluded from Extended Pleurectomy Decortication

(ESMO) Apr 14, 2016 - Although age as an isolated variable did not associate with patient outcome following extended pleurectomy decortication (EPD), elderly patients with nodal involvement and those not receiving adjuvant chemotherapy faired more poorly than similar, younger patients.
read article 



ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy

(ESMO) Apr 15, 2016 - Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit most from necitumumab added to gemcitabine and cisplatin chemotherapy, according to a subgroup analysis from the SQUIRE trial presented today at the European Lung Cancer Conference (ELCC) 2016 in Geneva, Switzerland.
read press release 



ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer

(ESMO) Apr 15, 2016 - The benefit of plasma genotyping to predict treatment benefit in patients with non-small-cell lung cancer (NSCLC) is confirmed in three studies presented today at the European Lung Cancer Conference (ELCC) 2016 in Geneva, Switzerland. Researchers however warned that plasma tests are unlikely to fully replace tissue biopsies.
read press release 



ELCC 2016 News: Comprehensive Molecular Profiling Shows Disparity Between Primary NSCLC Tumours and Metastases

(ESMO) Apr 15, 2016 - Important differences of up to 47% in the expression rates of biomarkers between the primary tumour and metastatic sites were detected using comprehensive molecular profiling of non-small-cell lung cancer (NSCLC) samples.
read news 



Rise In Oncologists Working For Hospitals Spurs Higher Chemo Costs: Study

(Kaiser Health News) Apr 15, 2016 - If you have cancer, chances are your outpatient chemotherapy treatment costs are higher if your oncologist works for a health care system than if she has her own practice, a recent study found.
read article 



Cancer Drug Labels Rarely Reflect Patient Experiences

(Reuters Health) Apr 14, 2016 - Information about the benefits and drawbacks patients experienced when taking a new cancer drug is rarely included on the product label, even though it could help doctors and patients make treatment choices, researchers say.
read article 



It’s Not Cancer: Doctors Reclassify a Thyroid Tumor

(New York Times) Apr 14, 2016 - An international panel of doctors has decided that a type of tumor that was classified as a cancer is not a cancer at all.
read article 



EC Approves Opdivo In NSCLC And Advanced Kidney Cancer

(European Pharmaceutical Review) Apr 14, 2016 - The European Commission has granted approval for the use of Bristol-Myers Squibb’s Opdivo (nivolumab) to treat patients with the most common forms of advanced lung and advanced kidney cancer.
read article 



FDA to Review Bristol-Myers’s Opdivo for Hodgkin Lymphoma

(Morningstar/Dow Jones Newswires) Apr 14, 2016 - The U.S. Food and Drug Administration has accepted Bristol-Myers Squibb Co.’s supplemental biologics license application to expand the use of its cancer drug Opdivo to patients who are facing difficult-to-treat variations of Hodgkin lymphoma, the pharmaceutical company said Thursday.
read article 



Paralyzed Man Regains Use of Hand After Receiving Brain Implant

(TIME/Associated Press) Apr 13, 2016 - An experimental device interprets his brain signals and stimulates his muscles.
read article 



Health Groups Ask Obama To Issue Delayed Tobacco Rule

(The Hill) Apr 13, 2016 - Dozens of health groups sent a letter to President Obama Wednesday, urging him to issue a long awaited final rule that allows the Food and Drug Administration to regulate all tobacco products for the first time, including cigars and electronic cigarettes.
read article 



CDC Confirms Zika Virus Causes Microcephaly, Other Birth Defects

(Washington Post/To Your Health) Apr 13, 2016 - Federal health officials confirmed Wednesday that the Zika virus causes a rare birth defect and other severe fetal abnormalities, marking a turning point in an epidemic that has spread to more than 40 countries and territories in the Americas and elsewhere.
read article (free registration required) 



Theranos Under Fire as U.S. Threatens Crippling Sanctions

(New York Times) Apr 13, 2016 - Federal regulators have threatened a series of stiff sanctions against Theranos, the embattled blood-testing company, including closing down its flagship laboratory and potentially barring its chief executive from owning or operating its labs for two years.
read article 



U.S. Drug Spending Climbs

(Wall Street Journal) Apr 14, 2016 - Total spending on prescription drugs in the U.S. rose 12.2% to nearly $425 billion in 2015, continuing a steep climb fueled by the introduction in recent years of expensive new drugs for cancer and infections, as well as price hikes for older drugs, according to a new report.
read article (paid subscription required)